Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Astellas PharmaAstellas Pharma
VS
Johnson & Johnson Innovative MedicineJohnson & Johnson Innovative Medicine
Astellas Pharma

Astellas Pharma

2-5-1, Nihonbashi-Honcho, Chuo-Ku, Tokyo, JP, 103-8411

Last Update: 05/04/2026

View Profile
Between 800 and 849
http://www.astellas.com/
802/1000Good

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and develo...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:12,110
Subsidiaries:1
12-month incidents
0
Known data breaches
0
Attack type number
0
Johnson & Johnson Innovative Medicine

Johnson & Johnson Innovative Medicine

N/A

Last Update: 31/03/2026

View Profile
807/1000Good

At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with co...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:37,729
Subsidiaries:10
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Astellas Pharma

Astellas Pharma

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Johnson & Johnson Innovative Medicine

Johnson & Johnson Innovative Medicine

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Astellas Pharma in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Johnson & Johnson Innovative Medicine in 2026.

Incidents

Incident History - Astellas Pharma (X = Date, Y = Severity)

Astellas Pharma cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Johnson & Johnson Innovative Medicine (X = Date, Y = Severity)

Johnson & Johnson Innovative Medicine cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Astellas Pharma

Astellas Pharma

Incidents
No explicit notable incidents reported.
Johnson & Johnson Innovative Medicine

Johnson & Johnson Innovative Medicine

Incidents
No explicit notable incidents reported.

FAQ

Between Astellas Pharma company and Johnson & Johnson Innovative Medicine company, which one has the best AI Cybersecurity Score ?
Between Astellas Pharma company and Johnson & Johnson Innovative Medicine company, which one has experienced more cyber incidents in the past ?
Between Astellas Pharma company and Johnson & Johnson Innovative Medicine company, which one has experienced more cyber incidents this year ?
Between Astellas Pharma company and Johnson & Johnson Innovative Medicine company, which one has experienced at least one ransomware attack ?
Between Astellas Pharma company and Johnson & Johnson Innovative Medicine company, which one has experienced at least one data breach ?
Between Astellas Pharma company and Johnson & Johnson Innovative Medicine company, which one has experienced at least one targeted cyberattack ?
Between Astellas Pharma company and Johnson & Johnson Innovative Medicine company, which one has experienced at least one vulnerability ?
Between Astellas Pharma company and Johnson & Johnson Innovative Medicine company, which one holds the most compliance certifications ?
Between Astellas Pharma company and Johnson & Johnson Innovative Medicine company, which one holds the fewest compliance certifications ?
Between Astellas Pharma company and Johnson & Johnson Innovative Medicine company, which one has the most subsidiaries ?
Between Astellas Pharma company and Johnson & Johnson Innovative Medicine company, which one has the largest number of employees ?
Between Astellas Pharma and Johnson & Johnson Innovative Medicine, which company holds both SOC 2 Type 1 certifications ?
Between Astellas Pharma and Johnson & Johnson Innovative Medicine, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Astellas Pharma or Johnson & Johnson Innovative Medicine ?
Which company is PCI DSS compliant - Astellas Pharma or Johnson & Johnson Innovative Medicine ?
Between Astellas Pharma and Johnson & Johnson Innovative Medicine, which company complies with HIPAA regulations for healthcare data ?
Between Astellas Pharma and Johnson & Johnson Innovative Medicine, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-26422
SUMMARY

clash-verge-service-ipc before 2.3.0 has a world-reachable IPC endpoint, leading to local privilege escalation.

PUBLISHED
Date2026-06-06
UPDATED
Date2026-06-06
RISK INFORMATION (Score: 8.4)
CVSS3
Base Score: 8.4
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.5
CVE-2026-11441
SUMMARY

A vulnerability was identified in theonedev onedev up to 15.0.5. This vulnerability affects the function canAccessIssue of the file /issues/ of the component Pull Request Handler. Such manipulation of the argument issue leads to improper authorization. It is possible to launch the attack remotely. Upgrading to version 15.0.6 is able to resolve this issue. It is advisable to upgrade the affected component.

PUBLISHED
Date2026-06-06
UPDATED
Date2026-06-06
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8
CVE-2026-11440
SUMMARY

A vulnerability was determined in theonedev onedev up to 15.0.5. This affects an unknown part of the file /repositories/{projectId}/default-branch of the component REST API. This manipulation of the argument project.defaultBranch causes improper authorization. It is possible to initiate the attack remotely. Upgrading to version 15.0.6 is able to mitigate this issue. Upgrading the affected component is advised.

PUBLISHED
Date2026-06-06
UPDATED
Date2026-06-06
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8
CVE-2026-11439
SUMMARY

A vulnerability was found in theonedev onedev up to 15.0.5. Affected by this issue is some unknown functionality of the file /projects/ of the component Parent Project Handler. The manipulation of the argument project.parentId results in improper authorization. The attack may be performed from remote. Upgrading to version 15.0.6 can resolve this issue. It is recommended to upgrade the affected component.

PUBLISHED
Date2026-06-06
UPDATED
Date2026-06-06
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8
CVE-2026-11438
SUMMARY

A vulnerability has been found in theonedev onedev up to 15.0.5. Affected by this vulnerability is an unknown functionality of the file /projects. The manipulation of the argument project.forkedFromId leads to improper authorization. The attack is possible to be carried out remotely. Upgrading to version 15.0.6 addresses this issue. Upgrading the affected component is recommended.

PUBLISHED
Date2026-06-06
UPDATED
Date2026-06-06
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8